Whether it is drug cost, conditions that require the payer to approve them, the patients health insurance plan, or the unaffordability of a plan that would cover weight loss, there are real-world barriers in our health care system, Shah said
In vitro cAMP assay For GLP-1R agonist activity, CHOK1 cells stably expressing human GLP-1R were used to measure peptideantibody conjugate-induced cAMP production in a homogenous time-resolved fluorescence assay (Cisbio, cat
These findings support the idea that reduced -cell mass as well as -cell dysfunction both contribute to the development and progressive course of DM
With the use of these new therapeutic agents, however, unexpected glucocorticoid-related mechanisms that can cause iatrogenic stimulation of prostate cancer growth have emerged, which might contribute to drug resistance and disease progression despite optimal ADT